Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,169 | -5,721 | -3,252 | -5,734 | -3,772 |
| Depreciation Amortization | -52 | -42 | -20 | 15 | 10 |
| Accounts receivable | 116 | -332 | -150 | -700 | -963 |
| Other Working Capital | 185 | -578 | -4 | -636 | -628 |
| Other Operating Activity | 683 | 668 | 292 | 1,359 | 1,557 |
| Operating Cash Flow | $-7,237 | $-6,005 | $-3,134 | $-5,696 | $-3,796 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,928 | -7,928 | -10,928 | N/A | N/A |
| PPE Investments | 12 | 12 | N/A | -50 | -63 |
| Investing Cash Flow | $-4,916 | $-7,916 | $-10,928 | $-50 | $-63 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4 | -3 | -2 | N/A | N/A |
| Common Stock Issued | 75 | 75 | N/A | 21,216 | 6,404 |
| Financing Cash Flow | $71 | $72 | $-2 | $21,216 | $6,404 |
| Beginning Cash Position | 16,823 | 16,823 | 16,823 | 1,353 | 1,353 |
| End Cash Position | 4,741 | 2,974 | 2,759 | 16,823 | 3,898 |
| Net Cash Flow | $-12,082 | $-13,849 | $-14,064 | $15,470 | $2,545 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,237 | -6,005 | -3,134 | -5,696 | -3,796 |
| Capital Expenditure | 0 | 0 | N/A | -50 | -63 |
| Free Cash Flow | -7,237 | -6,005 | -3,134 | -5,746 | -3,859 |